What is NDC 54973-4086?

54973-4086 is the product NDC for Bioplasma, Silicon dioxide 6 [hp_X]/1 + 11 more ingredients tablet, soluble, listed with the FDA by Hyland's Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Bioplasma (Silicon dioxide,Potassium chloride,Sodium sulfate,Ferrosoferric phosphate,Magnesium phosphate, Dibasic trihydrate,Sodium phosphate, Dibasic, Heptahydrate,Tribasic calcium phosphate,Potassium phosphate, Dibasic,Potassium sulfate,Sodium chloride,Calcium sulfate anhydrous,Calcium fluoride).

What is the active ingredient?

Silicon dioxide, Tribasic calcium phosphate, Ferrosoferric phosphate, Magnesium phosphate, Dibasic trihydrate, Sodium phosphate, Dibasic, Heptahydrate, Potassium chloride, Potassium phosphate, Dibasic, Potassium sulfate, Sodium chloride, Calcium sulfate anhydrous, Calcium fluoride, Sodium sulfate.

Hyland's Inc., NDC labeler code 54973. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bioplasma?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bioplasma NDC 54973-4086 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)54973-4086Labeler and product segments. Claims need a package NDC.

Product NDC at billing width54973-4086Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
54973-4086-1	5497340860154973408601	1 BOTTLE, PLASTIC in 1 CARTON (54973-4086-1) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTICMarketed from Dec 6, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bioplasma
Generic name (nonproprietary): silicon dioxide,potassium chloride,sodium sulfate,ferrosoferric phosphate,magnesium phosphate, dibasic trihydrate,sodium phosphate, dibasic, heptahydrate,tribasic calcium phosphate,potassium phosphate, dibasic,potassium sulfate,sodium chloride,calcium sulfate anhydrous,calcium fluoride
Active ingredients: Silicon dioxide — 6 [hp_X]/1Tribasic calcium phosphate — 3 [hp_X]/1Ferrosoferric phosphate — 3 [hp_X]/1Magnesium phosphate, Dibasic trihydrate — 3 [hp_X]/1Sodium phosphate, Dibasic, Heptahydrate — 3 [hp_X]/1Potassium chloride — 3 [hp_X]/1Potassium phosphate, Dibasic — 3 [hp_X]/1Potassium sulfate — 3 [hp_X]/1Sodium chloride — 6 [hp_X]/1Calcium sulfate anhydrous — 3 [hp_X]/1Calcium fluoride — 6 [hp_X]/1Sodium sulfate — 3 [hp_X]/1
Dosage form: Tablet, Soluble
Route: Oral
Labeler: Hyland's Inc.NDC labeler code 54973
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Dec 6, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 54973-4086_57d8baa7-b4c7-510c-e063-6294a90a5c8cSPL ID 57d8baa7-b4c7-510c-e063-6294a90a5c8cSPL set ID dd0a7ed2-d112-4b96-e053-2995a90ac6b6UNII ETJ7Z6XBU4, 91D9GV0Z28, 91GQH8I5F7, HF539G9L3Q, 70WT22SF4B, 660YQ98I10, CI71S98N1Z, 1K573LC5TV, 451W47IQ8X, E934B3V59H, O3B55K4YKI, 0YPR65R21J
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N454973408601 followed by a unit qualifier and the quantity

Package 54973-4086-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2026.

Indications (excerpt from the label)

Uses ■ Temporarily relieves: ■ cold symptoms ■ nervous tension ■ fatigue ■ headaches

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 54973-4086

What is NDC 54973-4086?: 54973-4086 is the product NDC for Bioplasma, Silicon dioxide 6 [hp_X]/1 + 11 more ingredients tablet, soluble, listed with the FDA by Hyland's Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bioplasma (Silicon dioxide,Potassium chloride,Sodium sulfate,Ferrosoferric phosphate,Magnesium phosphate, Dibasic trihydrate,Sodium phosphate, Dibasic, Heptahydrate,Tribasic calcium phosphate,Potassium phosphate, Dibasic,Potassium sulfate,Sodium chloride,Calcium sulfate anhydrous,Calcium fluoride).
What is the active ingredient?: Silicon dioxide, Tribasic calcium phosphate, Ferrosoferric phosphate, Magnesium phosphate, Dibasic trihydrate, Sodium phosphate, Dibasic, Heptahydrate, Potassium chloride, Potassium phosphate, Dibasic, Potassium sulfate, Sodium chloride, Calcium sulfate anhydrous, Calcium fluoride, Sodium sulfate.
Who is the labeler?: Hyland's Inc., NDC labeler code 54973. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bioplasma?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.